IRONWOOD PHARMACEUTICALS, INC. State and Local Income Tax Expense (Benefit), Continuing Operations
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported State and Local Income Tax Expense (Benefit), Continuing Operations of $2.70 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-02-16.
Discontinued › Expense Statement › Income Tax
us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations · last filed 2023-02-16
- IRONWOOD PHARMACEUTICALS, INC. state and local income tax expense (benefit), continuing operations for fiscal 2020 was $2.70M.
- IRONWOOD PHARMACEUTICALS, INC. state and local income tax expense (benefit), continuing operations for fiscal 2019 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. state and local income tax expense (benefit), continuing operations for fiscal 2018 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. state and local income tax expense (benefit), continuing operations for fiscal 2011 was $3.00K.
| Period end | State and Local Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2020-12-31 | $2.70M 10-K · filed 2023-02-16 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-18 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-17 |
| 2011-12-31 | $3.00K 10-K · filed 2014-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |